Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CSGN.SW Stock Summary
In the News
CSGN.SW Financial details
Company Rating
Sell
Market Cap
3.22B
Income
-7.31B
Revenue
14.35B
Book val./share
14.85
Cash/share
23.25
Dividend
0.05
Dividend %
6.12%
Employees
48.15K
Optionable
No
Shortable
Yes
Earnings
27 Jul 2023
P/E
-0.34
Forward P/E
-
PEG
-0.01
P/S
0.22
P/B
0.06
P/C
-
P/FCF
0.26
Quick Ratio
3.65
Current Ratio
3.54
Debt / Equity
3.81
LT Debt / Equity
3.52
-
-
EPS (TTM)
-2.58
EPS next Y
-
EPS next Q
-
EPS this Y
379.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-6.54%
Revenue Q/Q
-15.69%
EPS Q/Q
-68.28%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
1.6%
ROA
-1%
ROE
-16%
ROC
-
Gross Margin
100%
Oper. Margin
16%
Profit Margin
-51%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.66-5.924
52W High
-
52W Low
-
RSI
-
Rel Volume
1.23
Avg Volume
34.15M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.19149
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
CSGN.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.57 | 7.49 | 7.92 | 6.08 | 5.6 | |
Net income per share | 0.79 | 1.25 | 1 | -0.62 | -2.97 | |
Operating cash flow per share | 5 | -6.74 | -2.44 | 14.06 | 5.62 | |
Free cash flow per share | 4.57 | -7.21 | -2.89 | 13.52 | 5.04 | |
Cash per share | 40.01 | 37.61 | 52.83 | 63.29 | 28.75 | |
Book value per share | 17.22 | 15.97 | 15.99 | 16.73 | 18.37 | |
Tangible book value per share | 15.3 | 14.18 | 14.34 | 15.62 | 17.08 | |
Share holders equity per share | 17.22 | 15.97 | 15.99 | 16.73 | 18.37 | |
Interest debt per share | 74.04 | 72 | 71.16 | 73.35 | 72.84 | |
Market cap | 27.55B | 35.81B | 30.43B | 23.31B | 6.79B | |
Enterprise value | 102.59B | 116.8B | 71.97B | 46.05B | 109.93B | |
P/E ratio | 13.61 | 10.48 | 11.4 | -14.34 | -0.93 | |
Price to sales ratio | 1.43 | 1.75 | 1.44 | 1.46 | 0.49 | |
POCF ratio | 2.16 | -1.94 | -4.67 | 0.63 | 0.49 | |
PFCF ratio | 2.36 | -1.82 | -3.95 | 0.66 | 0.55 | |
P/B Ratio | 0.63 | 0.82 | 0.71 | 0.53 | 0.15 | |
PTB ratio | 0.63 | 0.82 | 0.71 | 0.53 | 0.15 | |
EV to sales | 5.32 | 5.71 | 3.41 | 2.88 | 7.99 | |
Enterprise value over EBITDA | 6.06 | 19.5 | 14.91 | 19.05 | 29.99 | |
EV to operating cash flow | 8.04 | -6.34 | -11.05 | 1.25 | 7.95 | |
EV to free cash flow | 8.79 | -5.92 | -9.34 | 1.3 | 8.88 | |
Earnings yield | 0.07 | 0.1 | 0.09 | -0.07 | -1.08 | |
Free cash flow yield | 0.42 | -0.55 | -0.25 | 1.52 | 1.82 | |
Debt to equity | 4.01 | 4.21 | 4.26 | 4.3 | 3.81 | |
Debt to assets | 0.23 | 0.23 | 0.23 | 0.25 | 0.32 | |
Net debt to EBITDA | 4.43 | 13.52 | 8.61 | 9.41 | 28.14 | |
Current ratio | 10.99 | 2.42 | 4.16 | 5.1 | 3.54 | |
Interest coverage | 1.27 | 0.36 | 0.44 | -0.16 | 0.28 | |
Income quality | 6.3 | -5.38 | -2.44 | -22.72 | -1.89 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.04 | |
Payout ratio | 0.33 | 0.2 | 0.27 | -0.16 | -0.04 | |
Sales general and administrative to revenue | 0.63 | 0.56 | 0.78 | 0.63 | 0.72 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Capex to operating cash flow | -0.09 | 0.07 | 0.18 | -0.04 | -0.1 | |
Capex to revenue | -0.06 | -0.06 | -0.06 | -0.09 | -0.1 | |
Capex to depreciation | -1.17 | -1.01 | -0.88 | -0.47 | -0.83 | |
Stock based compensation to revenue | 0 | -1.35 | -0.29 | 0.06 | 0.06 | |
Graham number | 17.53 | 21.2 | 18.97 | 15.26 | 35.06 | |
ROIC | 0.04 | 0.01 | 0.01 | -0.01 | 0.02 | |
Return on tangible assets | 0 | 0 | 0 | 0 | -0.01 | |
Graham Net | -231.27 | -223.41 | -222.89 | -201.94 | -164.05 | |
Working capital | 579.47B | 83.96B | 134.44B | 149.44B | 60.61B | |
Tangible asset value | 39.03B | 38.76B | 38.28B | 41.04B | 41.97B | |
Net current asset value | -87.42B | -600.46B | -585.92B | -525.74B | -401.56B | |
Invested capital | 4.01 | 4.21 | 4.26 | 4.3 | 3.81 | |
Average receivables | 47.8B | 42.15B | 38.14B | 27.76B | 17.99B | |
Average payables | 42.49B | 33.43B | 26.22B | 19.34B | 16.16B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 831.53 | 719.19 | 620.76 | 446.83 | 435.06 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.44 | 0.51 | 0.59 | 0.82 | 0.84 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | 0.08 | 0.06 | -0.04 | -0.16 | |
Capex per share | -0.43 | -0.47 | -0.45 | -0.54 | -0.59 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.61 | 1.59 | 1.25 | 1.25 | 0.97 | |
Net income per share | -0.8 | -0.1 | -0.57 | -1.45 | -0.46 | |
Operating cash flow per share | 3.16 | -1.68 | 0.5 | 3.08 | 2.78 | |
Free cash flow per share | 2.97 | -1.81 | 0.37 | 2.94 | 2.67 | |
Cash per share | 66.16 | 61.1 | 57.35 | 54.29 | 23.25 | |
Book value per share | 17.53 | 16.07 | 16.4 | 15.49 | 14.85 | |
Tangible book value per share | 16.26 | 14.98 | 15.29 | 14.35 | 13.81 | |
Share holders equity per share | 17.53 | 16.07 | 16.4 | 15.49 | 14.85 | |
Interest debt per share | 74.55 | 65.48 | 65.08 | 66.25 | 57.52 | |
Market cap | 22.28B | 20.3B | 15.15B | 11.1B | 8.4B | |
Enterprise value | 42.43B | 31.68B | 35.52B | 44.11B | 111.53B | |
P/E ratio | -2.78 | -18.32 | -2.38 | -0.69 | -1.5 | |
Price to sales ratio | 5.53 | 4.61 | 4.32 | 3.18 | 2.85 | |
POCF ratio | 2.81 | -4.37 | 10.76 | 1.29 | 0.99 | |
PFCF ratio | 2.98 | -4.06 | 14.46 | 1.35 | 1.03 | |
P/B Ratio | 0.51 | 0.46 | 0.33 | 0.26 | 0.19 | |
PTB ratio | 0.51 | 0.46 | 0.33 | 0.26 | 0.19 | |
EV to sales | 10.53 | 7.2 | 10.13 | 12.63 | 37.87 | |
Enterprise value over EBITDA | 31.11 | 44.56 | 338.3 | 24.64 | 78.6 | |
EV to operating cash flow | 5.35 | -6.82 | 25.23 | 5.13 | 13.18 | |
EV to free cash flow | 5.68 | -6.34 | 33.89 | 5.37 | 13.74 | |
Earnings yield | -0.09 | -0.01 | -0.11 | -0.36 | -0.17 | |
Free cash flow yield | 0.34 | -0.25 | 0.07 | 0.74 | 0.97 | |
Debt to equity | 4.23 | 4.06 | 3.94 | 4.23 | 3.81 | |
Debt to assets | 0.25 | 0.24 | 0.25 | 0.26 | 0.32 | |
Net debt to EBITDA | 14.77 | 16.01 | 193.98 | 18.44 | 72.68 | |
Current ratio | 5.63 | 5.45 | 6.22 | 6.24 | 3.54 | |
Interest coverage | -0.7 | 0.45 | -0.24 | 0.6 | 0.36 | |
Income quality | -3.95 | 16.77 | -0.88 | -2.13 | -6.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.05 | 0.62 | 0.76 | 0.63 | 1.28 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.01 | |
Capex to operating cash flow | -0.06 | 0.08 | -0.26 | -0.04 | -0.04 | |
Capex to revenue | -0.11 | -0.08 | -0.1 | -0.11 | -0.12 | |
Capex to depreciation | -0.23 | -0.98 | -0.87 | -0.73 | -0.78 | |
Stock based compensation to revenue | 0.04 | 0.06 | 0.07 | 0.06 | 0.01 | |
Graham number | 17.73 | 6.02 | 14.49 | 22.46 | 12.39 | |
ROIC | 0 | 0 | 0 | 0.07 | 0 | |
Return on tangible assets | 0 | 0 | 0 | -0.01 | 0 | |
Graham Net | -206.59 | -184.35 | -181.49 | -177.27 | -132.63 | |
Working capital | 150.38B | 155.44B | 147.2B | 136.4B | 60.61B | |
Tangible asset value | 40.84B | 41.44B | 42.75B | 40.07B | 41.97B | |
Net current asset value | -514.65B | -504.53B | -505.89B | -494.44B | -401.56B | |
Invested capital | 4.23 | 4.06 | 3.94 | 4.23 | 3.81 | |
Average receivables | 25.04B | 19.03B | 19.7B | 15.8B | 14.99B | |
Average payables | 19.29B | 15.29B | 14.73B | 12.07B | 13.74B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 372.57 | 437.23 | 462.29 | 349.72 | 501.22 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.24 | 0.21 | 0.19 | 0.26 | 0.18 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.05 | -0.01 | -0.03 | -0.09 | -0.03 | |
Capex per share | -0.18 | -0.13 | -0.13 | -0.14 | -0.11 |
CSGN.SW Frequently Asked Questions
What is Credit Suisse Group AG stock symbol ?
Credit Suisse Group AG is a CH stock and trading under the symbol CSGN.SW
What is Credit Suisse Group AG stock quote today ?
Credit Suisse Group AG stock price is $- today.
Is Credit Suisse Group AG stock public?
Yes, Credit Suisse Group AG is a publicly traded company.